Skip to main content

US Physical Therapy Value Stock - Dividend - Research Selection

Us physical therapy

ISIN: US90337L1089 , WKN: 923954

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It provides workforce performance solutions, including onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments for Fortune 500 companies, and other clients comprising insurers and their contractors. As of March 13, 2018, it operated 579 outpatient physical therapy clinics in 42 states; and managed 28 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. The company was founded in 1990 and is based in Houston, Texas.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Boston Scientific, U.S. Physical Therapy, 10x Genomics, GE HealthCare, and Integer Holdings Shares Are Falling, What You Need To Know

2025-09-10
A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading.

Outpatient & Specialty Care Q2 Earnings: U.S. Physical Therapy (NYSE:USPH) is the Best in the Biz

2025-09-08
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how outpatient & specialty care stocks fared in Q2, starting with U.S. Physical Therapy (NYSE:USPH).

Is Now The Time To Look At Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?

2025-08-31
While U.S. Physical Therapy, Inc. ( NYSE:USPH ) might not have the largest market cap around , it saw a decent share...

ASTH vs. USPH: Which Stock Is the Better Value Option?

2025-08-29
ASTH vs. USPH: Which Stock Is the Better Value Option?

1 Growth Stock to Stash and 2 We Turn Down

2025-08-25
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s punishment can be swift and severe when trajectories fall.

Baxter, U.S. Physical Therapy, Cogent, HNI, and TD SYNNEX Stocks Trade Up, What You Need To Know

2025-08-22
A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested that with inflation risks moderating and unemployment remaining low, the Federal Reserve might consider a shift in its monetary policy stance, including potential interest rate cuts. This outlook eased market concerns about prolonged high interest rates and their impact on economic growth. The prospe

ASTH or USPH: Which Is the Better Value Stock Right Now?

2025-08-13
ASTH vs. USPH: Which Stock Is the Better Value Option?

5 Must-Read Analyst Questions From U.S. Physical Therapy’s Q2 Earnings Call

2025-08-13
U.S. Physical Therapy’s second quarter saw a strong market reaction, reflecting positive surprise on both revenue and profitability. Management attributed the momentum to robust visit growth, driven by higher patient satisfaction and referrals, and successful execution in its injury prevention segment. CEO Christopher Reading highlighted that the company’s Net Promoter Score reached 93.5, indicating exceptional patient advocacy, while the industrial injury prevention business posted double-digit

U.S. Physical Therapy: The Bear Case Is On The Stretcher

2025-08-12
U.S. Physical Therapy stock has delivered steady revenue and profit growth. Click to read more on why USPH stock is not compelling enough for a buy.

Does U.S. Physical Therapy (USPH) Have the Potential to Rally 26.48% as Wall Street Analysts Expect?

2025-08-12
The average of price targets set by Wall Street analysts indicates a potential upside of 26.5% in U.S. Physical Therapy (USPH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.